Gene Name Synonym

IL-2, TCGF, lymphokine, Interleukin 2

Species

Human

Accession

P60568

Source

HEK293 cells

SPECIFICATIONS

Amino acid sequence

Ala21-Thr153 is expressed with a 10×His tag at the C terminus

Molecular Weight

16.8 kDa

Purity

>95.0% as determined by SDS-PAGE

Endotoxin

<5 EU mg^-1

Formulation

Lyophilized from sterile PBS, pH 7.4.Normally 5%-8% trehalose and   mannitol are added as protectants before lyophilization.

Reconstitution

Dissolved in sterile water, it is recommended to add 0.1% HSA or BSA   for long-term preservation.

STORAGE

Stability and Storage

12 months from date of receipt at -20°C to -70°C. After reconstitution,   it is stable at 4°C for 1 week or -20°C for almost 6 months (with carrier   protein). It is recommended to freeze aliquots at -20°C or -80°C for extended   storage.

BACKGROUND

Interleukin-2, also known as a T-cell growth factor, TCGF, Aldesleukin,   and IL2, is a secreted protein that belongs to the IL-2 family.   Interleukin-2 (IL-2), the first cytokine that was molecularly cloned,   was shown to be a T cell growth factor essential for the proliferation   of T cells and the generation of effector and memory cells.   Interleukin-2 / IL-2 was also the first cytokine shown to mediate its   effects via a specific IL-2 receptor, and it was also the   first interleukin to be cloned and expressed from a complementary DNA (cDNA)   library. Interleukin-2, also known as a T-cell growth factor, TCGF,   Aldesleukin, and IL2, is a secreted protein that belongs to the IL-2   family. IL-2 promotes the generation, survival, and functional   activity of Tregcells.  Interleukin-2 / IL-2 can stimulate B-cells,   monocytes, lymphokine-activated killer cells, natural killer cells, and   glioma cells. A recombinant form of Interleukin-2 / IL-2 for clinical   use is manufactured by Chiron Corporation with the brand name   Proleukin. It has been approved by the Food and Drug Administration (FDA)   for the treatment of cancers (malignant melanoma, renal cell cancer),   and is in clinical trials for the treatment of chronic viral infections,   and as a booster (adjuvant) for vaccines.

Data

SDS-PAGE

Bioactivity

Active Recombinant Human IL-2 Protein was determined by SDS-PAGE   with Coomassie Blue.

Measured in a cell proliferation assay using CTLL-2 cells. The ED50 for   this effect is 0.1-0.5 ng/mL.